Minerva surgical closes $30 million private placement of common stock

Santa clara, calif., feb. 09, 2023 (globe newswire) -- minerva surgical, inc. (nasdaq: utrs) (minerva surgical or the company), a women's health company focused on the treatment of abnormal uterine bleeding (aub), announced today that it has closed on the sale of 146,627,565 shares of its common stock in a private placement, led by accelmed partners (accelmed), with participation by new enterprise associates, at an offering price of $0.2046 per share. accelmed is now the controlling stockholder of minerva surgical.
UTRS Ratings Summary
UTRS Quant Ranking